What does european hospital liability — year 5 mean?

This metric represents the total insurance premiums or underwriting results generated by the European hospital liability product line during the fifth year of the reporting cycle. It serves as a key indicator of market penetration and risk exposure within the specialized healthcare professional liability sector in Europe. Investors use this data to evaluate the stability and growth trajectory of the company's regional insurance portfolio.

King Pharmaceuticals KG European Hospital Liability — Year 5

Other product segments

Commercial Auto Liability

14%—

General Liability

14%—

All other lines

3.6%—

International

-0.8%—

Similar metrics at other companies

CNAMedical Professional Liability — Year 5

13.2%+0.5pp

KMPRSpecialty Personal Automobile Insurance—Liability — Year 5

96.8%-0.6pp

AXSInsurance — Year 5

13.3%—

GLREHealth — Year 5

0%—

CNAGeneral Liability — Year 5

14.5%+0.7pp

CNAOther Professional Liability and Management Liability — Year 5

11.5%+1.0pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's european hospital liability — year 5.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's european hospital liability — year 5?: King Pharmaceuticals (KG) reported european hospital liability — year 5 of 11.9% in Q4 2025.
What does european hospital liability — year 5 mean?: This metric represents the total insurance premiums or underwriting results generated by the European hospital liability product line during the fifth year of the reporting cycle. It serves as a key indicator of market penetration and risk exposure within the specialized healthcare professional liability sector in Europe. Investors use this data to evaluate the stability and growth trajectory of the company's regional insurance portfolio.